Lifetech Pharmaceuticals: Stock trading abnormally fluctuates.

Li Sheng Pharmaceutical announced that the company's stock has increased by more than 20% for two consecutive trading days, which constitutes abnormal fluctuations in stock trading. After verification, it was found that there is no need to correct or supplement the information disclosed by the company in the previous period, and there is no significant undisclosed information that may affect the stock trading price. The company's recent operations are normal, and there have been no major changes in internal or external conditions. There are no major undisclosed matters or significant matters in the planning stage that the company, controlling shareholders, or actual controllers need to disclose. The controlling shareholders and actual controllers of the company are also not involved in buying or selling the company's stock.